Newsroom
From ambition to evidence: discover the story behind PARADIGM4TB in our new video
Following the publication of the first results from our flagship PARADIGM4TB clinical trial in The New England Journal of Medicine (NEJM), we're pleased to launch a new video highlighting the journey behind this milestone and the international collaboration driving our search for better tuberculosis (TB) treatments.
PARADIGM4TB is at the heart of our efforts to accelerate the development of shorter, safer and more effective TB treatment regimens. Through an innovative clinical trial platform, we're bringing together researchers, industry partners, clinical teams and TB community representatives to evaluate multiple treatment combinations within a single trial.
The publication of our first results marks an important step forward, with two promising treatment combinations selected for further investigation.
From ambition to evidence: the PARADIGM4TB story
Our new video, PARADIGM4TB: From Ambition to Evidence, takes viewers behind the scenes of this ambitious international effort.
Bringing together perspectives from researchers and the TB community, the video explores the vision behind PARADIGM4TB, how our innovative trial platform works in practice, and the progress made towards identifying promising new treatment regimens.
It also highlights the importance of collaboration in tackling one of the world's most pressing infectious disease challenges.
Building on an important milestone
The video launch follows our dedicated symposium at the Union World Conference on Lung Health in Rio de Janeiro, Brazil, on 19 November 2026.
During the symposium, Reimagining TB drug development: Phase 2 results from the UNITE4TB platform, our team presented the PARADIGM4TB findings in greater detail, alongside results from our ENABLE trial.
Together, the NEJM publication, Union symposium and new video highlight the progress we're making through international collaboration and innovative approaches to TB drug development.